Meiling Bao
Papers
1
Total Citations
4
H-Index
1
About
Dr. Meiling Bao is a dedicated urologic oncologist and researcher whose work centers on rare and aggressive genitourinary malignancies, with a particular focus on primary prostatic signet ring cell carcinoma (PPSRCC). Her landmark study, “Diagnosis and Management of Primary Prostatic Signet Ring Cell Carcinoma: Single-Center Experience,” provides critical insights into this exceptionally rare prostate cancer variant. Drawing from a decade of clinical data at the First Affiliated Hospital of Nanjing Medical University, Dr. Bao’s retrospective analysis of ten PPSRCC cases offers one of the few comprehensive clinical portraits of the disease, detailing its diagnostic challenges, treatment pathways, and prognostic patterns. Though her most-cited paper has garnered 4 citations—a reflection of the niche but vital nature of her work—its impact is substantial within the field of rare urologic cancers, where every case series advances clinical understanding. Dr. Bao’s contributions are especially valuable for clinicians and researchers confronting diagnostically elusive tumors, as her findings help refine management strategies for a condition with limited evidence. Her commitment to illuminating the shadows of rare prostate cancers marks her as a thoughtful and persistent voice in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1